These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 23836345)
1. Regorafenib (Stivarga) for metastatic colorectal cancer and GIST. Med Lett Drugs Ther; 2013 Apr; 55(1415):e36. PubMed ID: 23836345 [No Abstract] [Full Text] [Related]
9. Regorafenib: from bench to bedside in colorectal cancer. Shahda S; Saif MW Expert Rev Clin Pharmacol; 2013 May; 6(3):243-8. PubMed ID: 23656338 [TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumor - A review of clinical studies. Khoshnood A J Oncol Pharm Pract; 2019 Sep; 25(6):1473-1485. PubMed ID: 31068088 [TBL] [Abstract][Full Text] [Related]
11. [New molecular-targeted agents for colorectal cancer - regorafenib and aflibercept]. Kato S Gan To Kagaku Ryoho; 2013 Jan; 40(1):6-9. PubMed ID: 23306912 [TBL] [Abstract][Full Text] [Related]
13. Regorafenib: A Review of Its Use in Patients with Advanced Gastrointestinal Stromal Tumours. Shirley M; Keating GM Drugs; 2015 Jun; 75(9):1009-17. PubMed ID: 25998375 [TBL] [Abstract][Full Text] [Related]
14. Regorafenib: A Review in Metastatic Colorectal Cancer. Dhillon S Drugs; 2018 Jul; 78(11):1133-1144. PubMed ID: 29943375 [TBL] [Abstract][Full Text] [Related]
15. Regorafenib in the treatment of colorectal cancer. Majithia N; Grothey A Expert Opin Pharmacother; 2016; 17(1):137-45. PubMed ID: 26559195 [TBL] [Abstract][Full Text] [Related]
17. Current and Future Research Into the Mechanism of Action of Regorafenib. Yoshino T Clin Adv Hematol Oncol; 2019 Aug; 17 Suppl 12(8):14-16. PubMed ID: 32720934 [No Abstract] [Full Text] [Related]
18. Regorafenib in metastatic colorectal cancer: optimal dosing and patient selection recommendations. Grothey A Clin Adv Hematol Oncol; 2015 Aug; 13(8):514-7. PubMed ID: 26351814 [No Abstract] [Full Text] [Related]
19. Regorafenib in metastatic colorectal cancer. Sartore-Bianchi A; Zeppellini A; Amatu A; Ricotta R; Bencardino K; Siena S Expert Rev Anticancer Ther; 2014 Mar; 14(3):255-65. PubMed ID: 24559322 [TBL] [Abstract][Full Text] [Related]
20. Regorafenib: A novel tyrosine kinase inhibitor: A brief review of its therapeutic potential in the treatment of metastatic colorectal carcinoma and advanced gastrointestinal stromal tumors. Thangaraju P; Singh H; Chakrabarti A Indian J Cancer; 2015; 52(3):257-60. PubMed ID: 26905101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]